Predisposing Factors of Cardiovascular Events among COVID-19 Patients

Authors

  • Devina Gabriella Nugroho K.R.M.T Wongsonegoro Hospital Semarang Indonesia, Indonesia
  • Putri Rachmawati Dewi Dept of Cardiovascular Medicine, K.R.M.T Wongsonegoro Hospital Semarang Indonesia, Indonesia
  • Rima Adjani Nugroho K.R.M.T Wongsonegoro Hospital Semarang Indonesia, Indonesia
  • Santoso Jaeri Department of Medical Biology and Biochemistry, Faculty of Medicine, Universitas Diponegoro Semarang Indonesia Dept of Neurology National Hospital Diponegoro, Univesitas Diponegoro Semarang Indonesia, Indonesia http://orcid.org/0000-0002-0664-0039

DOI:

https://doi.org/10.21460/bikdw.v7i1.432

Keywords:

COVID-19, smoking, cardiovascular event

Abstract

Background COVID-19 is an infectious respiratory disease caused by SARS-CoV-2. During hospitalization, there is the possibility of cardiovascular events. The presence of these events might be related to some factors, unfortunately, there is limited evidence for these issues.Objective The aim of the study was to determine the independent predisposing factors associated with the occurrence of the cardiovascular event among COVID-19 patients during hospitalization.Method A retrospective study using medical records of hospitalized COVID-19 patients in K.R.M.T Wongsonegoro Hospital Semarang Indonesia, periods of June to September 2020. One hundred and one patients were included in the study. The subjects were classified into CVE groups and non-CVE, then the demographic characteristics and clinical data were collected. The Chi-Square, the Independent-T as well Mann-Whitney U test were used. The logistic regression then was used to determine the odds ratio of predisposing factors for CVE occurrence.Results There were significant associations for the history of cardiovascular disease, smoking, hypertension, use of angiotensin-converting enzyme inhibitor agents, the level of blood glucose and troponin I, and the systolic blood pressure at the first visit for CVE occurrence. Furthermore, the history of CVD increased the risk 0,007 times to get CVE.test.Conclusion The history of cardiovascular disease, smoking, hypertension, use of angiotensin-converting enzyme inhibitor agents, the level of blood glucose and troponin I, and the systolic blood pressure at first visit are the predisposing factors for the development of CVE among COVID-19 patients and patient who has the history of CVD have a high risk to get CVE during hospitalization.

References

Sattar Y, Ullah W, Rauf H, Hafeez HV, Yadav S, Chowdury M, Connerney M, Mamtani S, Pahuja M, Patel RD, Mir T, Almas T,Pacha HM, Alraies MC. COVID-19 cardiovascular epidemiology, cellular pathogenesis, clinical manifestations, and management. Int J Cardiol Heart Vasc. 2020. doi: 10.1016/j.ijcha.2020.100589.

Caillon A, Zhao K, Klein KO, Greenwood C, Lu Z, Paradis P, Schiffrin EL. High systolic blood pressure at hospital admission is an important risk factor in models predicting outcome of COVID-19 patients. American Journal of Hypertension. 2021 https://doi.org/10.1093/ajh/hpaa225.

The European Society for Cardiology. ESC Guidance for the Diagnosis and Management of CV Disease during the COVID-19 Pandemic. 2020. Available on https://www.escardio.org/Education/COVID-19-and-Cardiology/ESC-COVID-19-Guidance.

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054–1062. doi: 10.1016/S0140-6736(20)30566-3.

CDC. Smoking and cardiovascular disease. CDC. 2014. Available on https://www.cdc.gov/tobacco/data_statistics/sgr/50thanniversary/pdfs/fs_smoking_CVD_508.pdf.

Vázquez JC, Redolar-Ripoll D. COVID-19 outbreak impact in Spain: A role for tobacco smoking?. Tobacco Induced Diseases. 2020;18:30. doi:10.18332/tid/120005.

Roy A, Rawal I, Jabbour S, Prabhakaran D. Tobacco and Cardiovascular Disease: A Summary of Evidence. Cardiovascular, Respiratory, and Related Disorders 3rd edition. 2017;4. doi: 10.1596/978-1-4648-0518-9_ch4.

Zhao Q, Meng M, Kumar R, Wu Y, Huang J, Lian N, et al. The impact of COPD and smoking history on the severity of Covid-19: A systemic review and meta-analysis. Journal of Medical Virology. 2020. doi: 10.1002/jmv.2588.

Chen J, Wu C, Wang X, Yu J, Sun Z. The Impact of COVID-19 on Blood Glucose: A Systematic Review and Meta-Analysis. Front Endocrinol (Lausanne). 2020;11:574541. doi:10.3389/fendo.2020.574541.

Hussain A, Bhowmik B, do Vale Moreira NC. COVID-19 and diabetes: Knowledge in progress. Diabetes Res Clin Pract. 2020;162:108142. doi:10.1016/j.diabres.2020.108142.

Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. doi:10.1016/S0140-6736(20)30183-5.

Clerkin KJ, Fried AJ, Raikhelkar J, Sayer G, Griffin JM, Masoumi A, Jain SS, Burkhoff D, Kumaraiah D, Rabbani L, Schwartz A, Uriel N. In depth COVID-19 and cardiovascular disease. Circulation. 2020;141:1648–1655. DOI: 10.1161/CIRCULATIONAHA.120.046941.

Zhu L, She ZG, Cheng X, Qin JJ, Zhang XJ, Cai J, et al. Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes. Cell Metab. 2020; 31:1068–77.e3. doi:10.1016/j.cmet.2020.04.021

Downloads

Additional Files

Published

2022-08-16

Issue

Vol. 7 No. 1 (2022): BERKALA ILMIAH KEDOKTERAN DUTA WACANA

Section

Research

Citation Check

License

Authors who publish in Berkala Ilmiah Kedokteran Duta Wacana agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Attribution-ShareAlike 4.0 International (CC BY-SA 4.0) License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).

This work is licensed under CC BY-SA 4.0